Position in AMGN
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$363,568
-$14,670 QoQ
Shares Held
1,004
-6.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#2,408
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JFS WEALTH ADVISORS, LLC holds $17,102,053 across 16 Drug Manufacturers - General names. AMGN ranks #8 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
30,534 | $7,754,719 | |
| 2 | ABBV |
AbbVie Inc.
|
10,506 | $2,643,729 | |
| 3 | MRK |
Merck & Co., Inc.
|
18,599 | $2,389,971 | |
| 4 | LLY |
ELI LILLY & Co
|
901 | $1,080,686 | |
| 5 | PFE |
Pfizer Inc
|
40,840 | $983,427 | |
| 6 | NVS |
Novartis AG
|
4,893 | $766,830 | |
| 7 | AZN |
Astrazeneca PLC
|
2,497 | $473,481 | |
| 8 | AMGN |
Amgen Inc
This page
|
1,004 | $363,568 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $363,568 | 1,004 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $378,238 | 1,075 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $379,352 | 1,159 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $301,954 | 1,070 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $289,540 | 1,037 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $309,057 | 992 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $234,315 | 899 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $301,266 | 935 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $298,702 | 956 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $284,888 | 1,002 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $287,155 | 997 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $261,503 | 973 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $173,619 | 782 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $256,980 | 1,063 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $294,682 | 1,122 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $272,734 | 1,210 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $299,015 | 1,229 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $274,949 | 1,137 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $219,120 | 974 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $194,362 | 914 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $222,787 | 914 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $227,412 | 914 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $293,148 | 1,275 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $197,482 | 777 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $206,849 | 877 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $168,468 | 831 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||